Ventyx Biosciences's total assets for Q3 2025 were $211.47M, a decrease of -8.06% from the previous quarter. VTYX total liabilities were $20.10M for the fiscal quarter, a -2.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.